Biomea Fusion, Inc. BMEA
0.57 USD -0.01 (-2.38%)
Regular-session close
0.60 +0.02 +3.93%
After hours · Nov 20, 7:51 PM ET
0.5445 Day range 0.60
0.488 52-week range 2.21
- YTD
- -53.68%
- 1 year
- -42.56%
5D +0.0134 (+2.33%)
- Market cap
- 41.75M
- EPS (ttm)
- -0.10
- Shares out
- 36.24M
- Forward P/E
- -1.21
- YTD return
- -53.68%
- 1-year return
- -42.56%
- 50-day average
- 7.91
- 200-day average
- 8.85
- Enterprise value
- 74.90M
- Volume
- 1.13M
- Avg volume
- 2.21M
- Open
- 0.563
- Previous close
- 0.5884
- Day's range
- 0.5445 – 0.60
- 52-week range
- 0.488 – 2.21
- Beta
- -0.43
- Analysts
- Buy
- Price target
- 40.56 (+6960.5%)
Key statistics
- Price / book
- 1.91
- Free cash flow
- -65.44M
- Total cash
- 87.95M
- Total debt
- 9.57M
- Return on equity
- -104.51%
- Short % of float
- 44.56%
Fundamental scorecard
4 of 25 checks passed on BMEA’s reported financials
4of 25 checks passed
- Value 0 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
BMEA Revenue — quarterly 0
BMEA Net income — quarterly -6.18M
BMEA EPS — quarterly -0.09
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 29, 2024 | Sep 1, 2024 | -1.05 | -0.91 | +0.14 | +13.33% |
| Jul 31, 2024 | Jun 1, 2024 | -1.03 | -1.03 | 0.00 | 0.00% |
| Jul 31, 2024 | Jun 1, 2024 | -1.03 | — | — | — |
| May 2, 2024 | Mar 1, 2024 | -1.02 | -1.09 | -0.07 | -6.86% |
| May 2, 2024 | Mar 1, 2024 | -1.02 | — | — | — |
| Apr 1, 2024 | Dec 1, 2023 | -0.85 | -0.98 | -0.13 | -15.29% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | D. Boral Capital | main | Buy | Buy |
| Dec 18, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Dec 17, 2024 | D. Boral Capital | main | Buy | Buy |
| Dec 16, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Dec 10, 2024 | D. Boral Capital | main | Buy | Buy |
| Dec 10, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
About Biomea Fusion, Inc.
Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- biomeafusion.com
News
Your note
Sign in to keep a note on BMEA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| A2A PHARMACEUTICALS INC | Beneficial Owner of more than 10% of a Class of Security | Sale | May 31, 2023 | 3,500,000 |
| CHEN BIHUA X. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 29, 2023 | 0 |
| ERDTMANN RAINER M | President | Stock Gift | Dec 28, 2023 | 2,532,820 |
| FRIAS JUAN PABLO | Officer | Stock Award(Grant) | May 30, 2024 | 349 |
| HITCHCOCK MICHAEL J.M. | Director | Purchase | Sep 29, 2024 | 15,000 |
| VALLE FRANCO | Chief Financial Officer | Stock Award(Grant) | Nov 28, 2024 | 42,995 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.99% | 5,431,525 | 21.78M | Sep 29, 2024 |
| Cormorant Asset Management, LP | 9.85% | 3,570,872 | 14.32M | Sep 29, 2024 |
| Blackrock Inc. | 6.34% | 2,296,593 | 9.21M | Sep 29, 2024 |
| Baker Bros. Advisors, LP | 5.82% | 2,108,949 | 8.46M | Sep 29, 2024 |
| Vanguard Group Inc | 3.86% | 1,397,897 | 5.61M | Sep 29, 2024 |
| Millennium Management Llc | 3.80% | 1,378,408 | 5.53M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Growth Company Fund | 4.49% | 1,625,837 | 6.52M | Oct 30, 2024 |
| iShares Russell 2000 ETF | 1.98% | 718,868 | 2.88M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.96% | 711,773 | 2.85M | Sep 29, 2024 |
| Fidelity Growth Company K6 Fund | 1.71% | 620,200 | 2.49M | Oct 30, 2024 |
| Fidelity Series Growth Company Fund | 1.44% | 520,427 | 2.09M | Oct 30, 2024 |
| Fidelity Select Portfolios - Biotechnology | 1.08% | 392,129 | 1.57M | Oct 30, 2024 |
